Table 3.

Immediate and long-term post-treatment outcomes: overall cohort, 360° and mixed coiling groups result.

	Overall N: 148	360° Coiling n: 92	Mixed coiling n: 56	P
PACKING DENSITY
Packing density %	28.8%	27.7%	31.3%	0.30
Median IQR	(20.3%−41.1%)	(21.4%−41.1%)	(19.9%−41.1%)
IMMEDIATE OCCLUSION RAYMOND SCALE PER CORE LAB
Raymond class I & II	91.7%	90.2%	90.9%	1.0
Raymond class I	66.9%	66.3%	65.5%	1.0
DISCHARGE CLINICAL FUNCTIONAL ASSESSMENT (MRS)
mRS 0–2	89.9% (133)	92.4% (85)	85.7% (48)	0.26
mRS 0–1	84.5% (125)	88.0% (81)	78.6% (44)	0.16
DISCHARGE DISPOSITION
Acute rehabilitation	24.3% (36)	23.9% (22)	25% (14)	0.34
Home	73.0% (108)	72.8% (67)	73.2% (41)
Extended care facility	2.0% (3)	2.2% (2)	1.8% (1)
Expired in hospital	0.7% (1)	1.1% (1)	0% (0)
PROCEDURAL TECHNICAL AND CLINICAL OUTCOME
Symptomatic morbidity and mortality (up to discharge)	2.7% (4)
Mortality	0.7% (1)
Any intraoperative perforation	2.7% (4)	2.2% (2)	3.6% (2)	0.63
Symptomatic	1.4% (2)	1.1% (1)	1.8% (1)
Any thromboembolic event	4.7% (7)	4.3% (4)	5.4% (3)	1.0
Symptomatic	1.4% (2)	1.1% (1)	1.8% (1)
LONG-TERM OUTCOMES:
Raymond class I & II	90.4%	89.9%	90.9%	0.80
Raymond class I	66.2%	64.6%	70.5%	0.50
RETREATMENT RATE
Retreatment rate	2.4% (3)	2.5% (2)	2.1% (1)	0.9
OCCLUSION PROGRESSION PER CORE LAB
Progressive occlusion	16.8% (21)	18.8 (15)	12.8 (6)	0.46
Stable	68.0% (87)	67.5 (54)	70.2 (33)	0.84
Recanalization	15.2% (19)	13.8 (11)	17.0 (8)	0.62
LONG-TERM CLINICAL FUNCTIONAL ASSESSMENT (MRS): 135 (83, 52)
mRS 0–2	94.8% (128)	97.6% (81)	90.4% (47)	0.52
mRS 0–1	93.3% (126)	96.4% (80)	88.5% (46)	0.49
Adverse event since discharge	3.1% (4)	2.5% (2)	4.3% (2)	0.64